Navigation Links
Lifecycle Biotechnologies Announces Promotion of Ashley Wilhelm to Customer Outcomes Manager
Date:9/7/2017

Lifecycle Biotechnologies, a leading life science tools and services supplier, today announced the promotion of Ashley Wilhelm to the role of Customer Outcomes Manager. In this role, Ms. Wilhelm will oversee the customer service departments for Lifecycle and it’s three brands, Boval BioSolutions, Chata Biosystems, and VI Plastics. Ms. Wilhelm will be responsible for strengthening customer and partner relationships and ensuring the highest level of service is provided.

Holding a BA Degree from American University, Ms. Wilhelm joined Lifecycle in 2015 and served as Account Manager exclusively for Chata Biosystems. Demonstrating impressive abilities and improving customer interactions, she will now take on a bigger role in the company’s expansion and growth plans.

“This is a well-deserved promotion and we look forward to Ashley’s increased contributions which have, and will continue, to positively impact us and our customers,” said Aaron Schieving, Director of Sales and Marketing for Lifecycle Biotechnologies. “Bringing her skills and ideas to all three brands will be influential in what’s to come at Lifecycle.”

Based in Ft. Worth, TX, Lifecycle Biotechnologies has served the life science industry for nearly 40 years. The company owns and operates three brands each focused on providing products for the unique and unmet needs of the biopharmaceutical, pharmaceutical, regenerative medicine, and industrial segments it serves. Products such as Bovine Serum Albumin (BSA), Human Serum Albumin (HSA), chemicals and reagents, and blow molded plastic products. For more info on Lifecycle Biotechnologies, please visit: http://www.LifecycleBio.com.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14661267.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Bioclinica Introduces Pharmaceutical Industry’s First End-to-End Clinical Financial Lifecycle Platform
2. Lifecycle Biotechnology Today Announced the Hiring of Aaron Benz as Business Development Manager for their Chemical and Reagent Brand, Chata Biosystems
3. PointCross announces SaaS offerings on the cloud to span the entire lifecycle of eData submissions to FDA
4. Model of viral lifecycle could help in finding a cure for hepatitis B
5. Wyle Wins NASAs Fully Integrated Lifecycle Mission Support Services Contract
6. Patheon-Sponsored Event to Highlight “Product Enhancement Through Complex Dosage Forms: Adding Value to Products’ Lifecycle Management”
7. Technical Workshops at OrthoTec 2013 Focus on Risk Management Throughout Medical Device Lifecycle and Robust Material Selection Process Development
8. Sentien Biotechnologies, Inc. Announces Open Enrollment in Phase 1/2 Trial of SBI-101 for Patients with Acute Kidney Injury
9. Stellar Biotechnologies Reports First Quarter 2017 Financial Results
10. Base Pair Biotechnologies, Inc. and Nexmos, Inc. Create the First DNA Aptamers that Inhibit Vitamin C Oxidation
11. AVALANCHE BIOTECHNOLOGIES, INC. SHAREHOLDER UPDATE: Kessler Topaz Meltzer & Check, LLP Announces Update to Shareholder Class Action Against Avalanche Biotechnologies, Inc. -- AAVL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2020)... , ... July 16, 2020 , ... ... to aid in the early detection and prevention of high-burden diseases, and Centric ... US-based hospitals and healthcare organizations to utilize existing data in order to identify ...
(Date:7/10/2020)... ... July 09, 2020 , ... In most research using ... suppress pigment formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. ... has been using the zebrafish model to investigate the causes of leukaemia and ...
(Date:7/1/2020)... ... 29, 2020 , ... MedShift , a leading medical ... many obstacles created as a result of COVID-19. As a provider at the ... practices and medical manufacturers by expanding access to device offerings, technology services, and ...
(Date:6/28/2020)... ... June 25, 2020 , ... With the COVID-19 pandemic impacting ... treatment. In an effort to better understand the cellular responses to COVID-19, the ... dataset portraying therapeutic compound effects from over 1,600 approved and referenced molecules on ...
Breaking Biology Technology:
(Date:7/10/2020)... (PRWEB) , ... July 09, 2020 , ... Today CJ ... Advantage, which will share insight on the “fifth taste” phenomenon that is revolutionizing ingredient ... The Umami Advantage will be live on Monday, July 13, 2020 at11:00 AM (CDT) ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio ... findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease ... hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, this ...
(Date:7/1/2020)... N.J. (PRWEB) , ... July 01, 2020 , ... ... announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in ... the company’s existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot ...
Breaking Biology News(10 mins):